PhRMA closes its D.C. headquarters after visitor tests positive for coronavirus
WASHINGTON — The Pharmaceutical Research and Manufacturers of America, the Washington lobbying arm for the drug industry, will close for the remainder of the week after an individual exposed to coronavirus entered the group’s office on March 5.
“Based on initial conversations with public health offices and out of an abundance of caution, PhRMA has closed our Washington, D.C., headquarters for the remainder of the week and will conduct a deep cleaning of all our facilities. We have also asked those individuals who were in the meeting with the diagnosed person to self-quarantine and not return to our offices until March 20,” PhRMA spokesperson Robert Zirkelbach wrote in a statement.
